PlasmaGen BioSciences has chosen DCX Strategies to transform its Digital capabilities to Improve Digital Customer Experience (DCX)

PHILADELPHIA, Jan. 11, 2022 /PRNewswire-PRWeb/ -- PlasmaGen BioSciences, a leading biopharmaceutical organization, specializing exclusively in Plasma Protein and Specialty Care Therapy, has selected DCX Strategies to help them transform their digital capabilities to improve Digital Customer Experience (DCX). DCX Strategies will use its proprietary DCX-RATER methodology to craft a personalized Digital strategy for PlasmaGen BioSciences.

PlasmaGen BioSciences' determination to improve their patients' health and quality of life because of its commitment to innovation and quality has led them to discover that they needed a digital transformation. DCX Strategies, with their focus on digital strategy and the management experience in the plasma protein and specialty therapeutics industry, fit the description of what they needed and was chosen to provide strategy advise on how PlasmaGen could transform their digital customer experience (DCX).

Dr. Ranjeet Ajmani, Chief Executive Officer of PlasmaGen BioSciences, explains, "PlasmaGen has chosen DCX Strategies to transform our digital presence to provide digital offerings that further our mission to improving the health and quality of life of patients. We are impressed with the digital and CX strategy focus and the relevant experience that the DCX Strategies management has in the plasma protein and specialty care therapeutics industry."

As part of this digital strategy work, DCX Strategies will apply its proprietary DCX-RATER methodology to develop PlasmaGen's:

• Omni-channel strategy to engage with customers on multiple digital channels of communication (website, mobile apps, chat bots, news, and social media)
• Digital Personas to understand how digital customers are thinking, feeling, and doing at each stage of their digital interaction to map the customer's digital journey
• Digital Roadmap to craft an industry-best digital customer experience (DCX) that is relevant and futuristic but also compliant with lifesciences and plasma protein therapeutics industry requirements

The digital strategy work will be conducted in three phases:

• Phase 1 - Collecting the voice-of-the-customer using the company's proprietary DCX-VOC tool to understand current customer experiences vs. desired outcomes for both consumers and non-consumers of the digital platform
• Phase 2 – Discovery workshop using the company's proprietary DCX-DISC and DCX-IDEA tools to understand business and marketing challenges, goals, and compliance requirements
• Phase 3 – Strategy & roadmap development in collaboration with PlasmaGen's leadership to outline organization capabilities across the digital maturity map to develop a strategy to get PlasmaGen to the next stage of digital maturity.

Dr. Nagesh Ramesh, Chief Digital Officer of DCX Strategies, said, "DCX Strategies is excited to partner with PlasmaGen to transform its digital customer experience (DCX). In addition to providing a frictionless digital experience for existing customers, our goal is to also bring new customers to the digital platform with compelling digital products and services that increase convenience."

DCX Strategies has kickstarted the process of transforming PlasmaGen's digital customer experience (DCX), and the results will be visible soon.

Media Contact

Dr. Nagesh Ramesh, DCX Strategies, LLC, 1 6102008101, [email protected]

SOURCE DCX Strategies, LLC